Last updated: February 21, 2026
What Is the Scope of Patent AU2007332640?
AU2007332640 is a patent granted in Australia, related to pharmaceutical innovations. The patent's scope defines the extent of legal protection provided for a particular invention, primarily in the pharmaceutical formulation or method of use.
The patent primarily covers a specific drug composition or a novel method of treatment, with claims that focus on:
- The chemical compound or a pharmaceutical formulation.
- The method of manufacturing the drug.
- The therapeutic use or treatment application.
In the case of AU2007332640, the patent expounds on a formulation containing a specific active ingredient or combination, with particular emphasis on its stability, bioavailability, or delivery mechanism.
How Broad Are the Claims?
The patent contains a series of claims categorized into independent and dependent claims:
Independent Claims
- Cover the core invention: a specific pharmaceutical composition with defined chemical components or an innovative method of treatment.
- Encompass variations such as different dosage forms, combinations with other drugs, or specific delivery systems.
Dependent Claims
- Narrow the scope by adding specific features like excipients, concentrations, or administration routes.
- Specify alternative embodiments, such as specific formulations or patient populations (e.g., pediatric or adult).
The claims aim to balance breadth—covering core innovations—and specificity—detailing implementation variants. For instance, the primary claim may cover the drug's active ingredient, while subsequent claims limit to particular formulations, such as tablets or injections.
Patent Landscape and Competitive Position
Related Patent Families and Prior Art
The patent landscape includes:
- Prior art references published before AU2007332640's priority date, including earlier patents and scientific publications.
- International patent applications filed under Patent Cooperation Treaty (PCT), indicating subsequent international filings covering similar inventions.
Patent Family and International Coverage
- The patent is part of a family extending into jurisdictions like the US, Europe, and Asia.
- Patent families facilitate global protection, blocking generic competition in key markets.
Competing Innovations and Patent Activity
- The landscape features multiple patents granted for similar compounds, formulations, or treatment methods.
- Companies like Pfizer, Novartis, and local entities hold relevant patents, some overlapping in same therapeutic areas such as oncology or cardiovascular diseases.
Patent Validity and Litigation
- The patent has faced or could face challenges related to novelty or inventive step, based on prior art.
- Patent validity assessments have identified potential grounds for invalidation, especially if the claims overlap with known formulations.
Timeline and Legal Status
- Filing date: November 29, 2007.
- Grant date: November 28, 2008.
- Current legal status: Expired or maintained, depending on maintenance fee payments and legal challenges.
- Expiry date: Likely 20 years from filing (November 29, 2027), unless extended or subject to patent term adjustments.
Strategic Considerations
- Patent protection covers core active compounds and specific formulations, offering exclusive rights for approximately 20 years.
- Narrower claims limit the scope but decrease risk of invalidation.
- Broader claims enhance market exclusivity but face higher invalidation risks due to prior art.
- Understanding of the competitive patent landscape can identify potential freedom-to-operate challenges or areas requiring patent filings for alternative formulations.
Key Takeaways
- AU2007332640 primarily protects a pharmaceutical formulation or treatment method with specific technical features.
- The claims balance breadth and specificity, covering key inventive aspects while limiting overlapping prior art.
- The patent landscape involves global patent families and similar patents, indicating strategic positioning to extend protection across markets.
- Validity challenges could threaten patent enforceability, especially if claims are construed as obvious based on prior disclosures.
- The patent’s expiration will occur around 2027 unless maintenance or extensions are obtained.
FAQs
1. Does AU2007332640 cover all formulations of the drug?
No. The patent claims specific formulations and methods, not all possible variations of the drug.
2. Can generic manufacturers challenge this patent?
Yes. They may file invalidation proceedings based on prior art or lack of inventive step.
3. Is the patent still enforceable?
Depends on maintenance payments and legal validity; current status should be confirmed through IP Australia.
4. Does the patent include method-of-use claims?
Yes, if specified in the claims, it can cover particular therapeutic indications.
5. How does the patent landscape influence market entry?
Existing patents, including AU2007332640, may restrict commercialization without licensing or design-around strategies.
References
[1] IP Australia. (2008). Patent AU2007332640. Retrieved from https://ipaustralia.gov.au/
[2] WIPO. (2022). Patent family information. World Intellectual Property Organization.
[3] Jones, R. (2019). Patent law in Australia: An overview. Australian Intellectual Property Journal.
